Hamartoma overview: Difference between revisions

Jump to navigation Jump to search
Maria Villarreal (talk | contribs)
No edit summary
Maria Villarreal (talk | contribs)
Line 46: Line 46:
===Medical therapy===
===Medical therapy===
===Surgery===
===Surgery===
===Primary Prevention===
There is no established method for prevention of hamartomas.


===Secondary Prevention===


 
Secondary prevention strategies following hamartomas include periodical imaging surveillance with CT scan.<ref name="pmid23830790">{{cite journal |vauthors=Amini B, Huang SY, Tsai J, Benveniste MF, Robledo HH, Lee EY |title=Primary lung and large airway neoplasms in children: current imaging evaluation with multidetector computed tomography |journal=Radiol. Clin. North Am. |volume=51 |issue=4 |pages=637–57 |year=2013 |pmid=23830790 |doi=10.1016/j.rcl.2013.04.005 |url=}}</ref>


==References==
==References==

Revision as of 16:48, 8 December 2015

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma overview

CDC on Hamartoma overview

Hamartoma overview in the news

Blogs on Hamartoma overview

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

A hamartoma (from Greek hamartion “bodily defect”) is a focal malformation that resembles a neoplasm in the tissue of its origin. This is not a malignant tumor, and it grows at the same rate as the surrounding tissues. It is composed of tissue elements normally found at that site but that are growing in a disorganized fashion.[1]They occur in many different parts of the body and are most often asymptomatic and undetected unless seen on an image taken for another reason (incidentaloma).

Historical Perspective

Classification

Pathophysiology

Causes

Hamartomas may be caused by an abnormal formation of normal tissue.[2]

Differential diagnosis

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

If left untreated, hamartomas normally grow slowly and may progress to develop a considerable size, however pulmonary hamartomas have low or no malignant potential. Nevertheless, it is essential to rule out the presence of cancer. Common complications of hamartomas will depend on the location and size. Prognosis is generally regraded as excellent.[3]

Diagnosis

Staging

History and Symptoms

Physical examination

Laboratory tests

Chest X-ray

CT

MRI

Ultrasound

There are no ultrasound findings associated with Hamartoma.

Other Diagnostic Studies

Treatment

Medical therapy

Surgery

Primary Prevention

There is no established method for prevention of hamartomas.

Secondary Prevention

Secondary prevention strategies following hamartomas include periodical imaging surveillance with CT scan.[4]

References

  1. Mitchell, Richard; Kumar, Vinay; Fausto, Nelson; Abbas, Abul K.; Aster, Jon (2011). Pocket Companion to Robbins & Cotran Pathologic Basis of Disease (8th ed.). Elsevier Saunders. pp. 147. ISBN 978-1416054542.
  2. Hamartomas. Wikipedia https://en.wikipedia.org/wiki/Hamartoma Accessed on December 08, 2015
  3. Marchiori E, Souza AS, Franquet T, Müller NL (2005). "Diffuse high-attenuation pulmonary abnormalities: a pattern-oriented diagnostic approach on high-resolution CT". AJR Am J Roentgenol. 184 (1): 273–82. doi:10.2214/ajr.184.1.01840273. PMID 15615988.
  4. Amini B, Huang SY, Tsai J, Benveniste MF, Robledo HH, Lee EY (2013). "Primary lung and large airway neoplasms in children: current imaging evaluation with multidetector computed tomography". Radiol. Clin. North Am. 51 (4): 637–57. doi:10.1016/j.rcl.2013.04.005. PMID 23830790.


Template:WikiDoc Sources